A carregar...
A Phase I study of Sirolimus and Bevacizumab in Patients with Advanced Malignancies
BACKGROUND: We performed a single institution, phase I study of sirolimus and bevacizumab, in order to determine the dose limiting toxicity (DLT) and recommended phase II doses. PATIENTS AND METHODS: Eligible patients had previously treated advanced malignancies and were enrolled in three cohorts. S...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4116678/ https://ncbi.nlm.nih.gov/pubmed/21439817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2011.02.017 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|